South Korean deal fuels growth for Memphis biotech biz
Hera Health Solutions CEO Idicula Mathew (left) signs an agreement with Geovista CEO Dr. Gook Jun Ahn in Seoul, South Korea, on Oct. 17. (Courtesy Idicula Mathew)
Hera Health is experiencing a growth spurt after striking a deal that allows a South Korean company to use technology developed in Memphis in Asia’s veterinary-drug market.
Topics
Hera Health Solutions Idicula Mathew pharmaceuticals biotech EpiCenterAisling Mäki
Aisling Mäki has been writing about Memphis since she moved to the city more than 20 years ago. She’s worked for print, digital and broadcast news outlets, including Memphis Daily News and Action News 5 (WMC), as well as public relations agencies. Her work has earned awards from The Associated Press, Tennessee Press Association, Society of Professional Journalists and Public Relations Society of America.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.